JPMorgan Chase & Co’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,510,226
| Closed | -$26.5M | – | 6183 |
|
|
2021
Q3 | $26.5M | Buy |
1,510,226
+1,472,671
| +3,921% | +$25.9M | ﹤0.01% | 1382 |
|
|
2021
Q2 | $364K | Buy |
+37,555
| New | +$364K | ﹤0.01% | 4175 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5494 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5238 |
|
|
2020
Q2 | – | Sell |
-251,272
| Closed | -$1.02M | – | 5079 |
|
|
2020
Q1 | $1.02M | Buy |
+251,272
| New | +$1.02M | ﹤0.01% | 2935 |
|
|
2018
Q3 | – | Sell |
-5,125
| Closed | -$31K | – | 4928 |
|
|
2018
Q2 | $31K | Sell |
5,125
-168
| -3% | -$1.02K | ﹤0.01% | 4459 |
|
|
2018
Q1 | $38K | Buy |
+5,293
| New | +$38K | ﹤0.01% | 4240 |
|
|
2017
Q1 | – | Sell |
-4,800
| Closed | -$27K | – | 4591 |
|
|
2016
Q4 | $27K | Buy |
+4,800
| New | +$27K | ﹤0.01% | 4121 |
|
|
2016
Q2 | – | Sell |
-3,505
| Closed | -$32K | – | 4418 |
|
|
2016
Q1 | $32K | Buy |
+3,505
| New | +$32K | ﹤0.01% | 3513 |
|